| Literature DB >> 29415046 |
Stefanie U Wetzels1, Melanie Eger2, Marion Burmester2, Lothar Kreienbrock3, Amir Abdulmawjood4, Beate Pinior5, Martin Wagner1, Gerhard Breves2, Evelyne Mann1.
Abstract
The rumen simulation technique (RUSITEC) is a well-established semicontinuous in vitro model for investigating ruminal fermentation; however, information on the stability of the ruminal bacterial microbiota and metabolome in the RUSITEC system is rarely available. The availability of high resolution methods, such as high-throughput sequencing and metabolomics improve our knowledge about the rumen microbial ecosystem and its fermentation processes. Thus, we used Illumina MiSeq 16S rRNA amplicon sequencing and a combination of direct injection mass spectrometry with a reverse-phase LC-MS/MS to evaluate the dynamics of the bacterial community and the concentration of several metabolites in a RUSITEC experiment as a function of time and in response to a challenge with a pathogenic Clostridium perfringens (C. perfringens) strain. After four days of equilibration, samples were collected on days 5, 6, 7, 10, 12 and 15 of the steady-state and experimental period. From a total of six fermenters, three non-infected fermenters were used for investigating time-dependent alterations; three fermenters were incubated with C. perfringens and compared with the non-infected vessels at days 10, 12 and 15. Along the time-line, there was no statistically significant change of the overall bacterial community, however, some phylotypes were enriched at certain time points. A decrease in Fibrobacter and Elusimicrobia over time was followed by an increase in Firmicutes and Actinobacteria. In contrast, classical fermentation measurements such as pH, redox potential, NH3-N, short chain fatty acids and the concentrations of metabolites determined by metabolomics (biogenic amines, hexoses and amino acids) remained stable throughout the experiment. In response to C. perfringens addition the concentrations of several amino acids increased. Although the overall bacterial community was not altered here either, some minor changes such as an enrichment of Synergistetes and Bacteroidetes were detectable over time. In conclusion, both, the bacterial community composition and the metabolome in the RUSITEC system were relatively stable during the experiment.Entities:
Mesh:
Year: 2018 PMID: 29415046 PMCID: PMC5802913 DOI: 10.1371/journal.pone.0192256
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Experimental setup.
(A) 4 days equilibration period (yellow), 3 days steady-state period (orange) and 8 days experimental period (red). (B) Three non-infected fermenters from the steady-state- and experimental period are depicted in A-C and three C. perfringens infected fermenters in D-F. S = RUSITEC effluent sampling, yellow “x” = C. perfringens inoculation. The red boxes indicate C. perfringens-spiked fermenters.
The 50 most abundant OTUs are shown with the respective relative abundance in the RUSITEC samples, sequence similarity to Greengenes hits, match length and accession number.
| OTU | Rel. ab. | Sim. | Match length (bp) | Accession No. | Greengenes best hit |
|---|---|---|---|---|---|
| 2456812 | 7.50 | 100 | 543 | NR_028866.1 | |
| 768947 | 5.92 | 100 | 543 | AY699286.1 | |
| 266210 | 2.19 | 100 | 552 | EU728750.1 | |
| 312373 | 2.02 | 97.61 | 543 | AB501154.1 | |
| 578085 | 1.77 | 97.24 | 543 | AB501162.1 | |
| 811229 | 1.76 | 98.53 | 543 | AB501173.1 | |
| 84193 | 1.67 | 82.14 | 543 | AB255367.1 | |
| 579278 | 1.39 | 91.87 | 529 | NZ_AAXG02000037.1 | |
| 576416 | 1.31 | 83.06 | 543 | AY643076.1 | |
| 4358602 | 1.17 | 100 | 552 | AB186315.1 | |
| 209705 | 1.09 | 82.5 | 543 | AB541983.1 | |
| 813220 | 1.09 | 95.11 | 552 | X81137.1 | |
| 254969 | 1.04 | 83.79 | 543 | AB554231.1 | |
| 266445 | 1.00 | 100 | 552 | EF120372.1 | |
| 582088 | 0.86 | 97.42 | 543 | AB501163.1 | |
| 581091 | 0.80 | 99.82 | 551 | Y09434.1 | |
| 137580 | 0.78 | 98.36 | 550 | EF120372.1 | |
| 538223 | 0.77 | 99.82 | 552 | EF120372.1 | |
| 4438135 | 0.72 | 82.14 | 543 | AY918928.1 | |
| 343181 | 0.66 | 82.99 | 541 | AB078046.1 | |
| New.Ref_OTU144 | 0.65 | 98.01 | 552 | AB186315.1 | |
| 559781 | 0.63 | 83.61 | 543 | X97245.1 | |
| 848968 | 0.59 | 92.08 | 543 | AB501157.1 | |
| 213576 | 0.59 | 96.13 | 543 | AB501162.1 | |
| 831922 | 0.58 | 86.2 | 529 | U88891.1 | |
| 324495 | 0.58 | 88.56 | 542 | AB331896.1 | |
| New.Ref.OTU379 | 0.58 | 98.19 | 552 | EU163503.1 | |
| New.Ref.OTU373 | 0.57 | 98.73 | 552 | AB186315.1 | |
| 1082539 | 0.57 | 100 | 552 | EU163503.1 | |
| 738975 | 0.56 | 87.07 | 549 | DQ833400.1 | |
| 272580 | 0.55 | 93.74 | 543 | AB501163.1 | |
| 592852 | 0.55 | 96.32 | 543 | AB501173.1 | |
| 637375 | 0.54 | 89.25 | 549 | DQ833400.1 | |
| 635310 | 0.50 | 83.61 | 543 | NR_025910.1 | |
| New.Ref.OTU86 | 0.49 | 82.32 | 543 | AF118419.1 | |
| New.Ref.OTU266 | 0.48 | 98.19 | 552 | AB186315.1 | |
| New.Ref.OTU56 | 0.47 | 82.66 | 548 | EU281854.1 | |
| 628517 | 0.45 | 86.09 | 532 | DQ903989.1 | |
| 330492 | 0.43 | 91.08 | 527 | X76161.1 | |
| 338757 | 0.42 | 98.91 | 552 | AB186315.1 | |
| 589852 | 0.42 | 100 | 526 | NR_026315.1 | |
| 546360 | 0.40 | 95.76 | 543 | AB501173.1 | |
| 237728 | 0.40 | 82.5 | 543 | GU470889.1 | |
| 144161 | 0.39 | 94.84 | 543 | AF218619.1 | |
| 348764 | 0.39 | 86.74 | 528 | AB186360.1 | |
| New.Ref.OTU303 | 0.39 | 84.12 | 548 | AF183405.1 | |
| New.Ref.OTU159 | 0.39 | 85.45 | 543 | AB510702.1 | |
| 732053 | 0.38 | 84.67 | 548 | EU281854.1 | |
| 548324 | 0.37 | 84.31 | 548 | EU281854.1 | |
| 262849 | 0.37 | 96.01 | 552 | NR_026450.1 | |
| 353910 | 0.36 | 86.53 | 527 | AJ229251.1 | |
| New.Ref.OTU97 | 0.36 | 85.5 | 545 | AB547676.1 | |
| 99436 | 0.35 | 99.64 | 552 | AB198428.1 | |
| New.Ref.OTU512 | 0.35 | 98.55 | 552 | EU163503.1 |
1 Rel. ab. = Relative abundance
2 Sim. = Sequence similarity to best Greengenes hit
3 Best Greengenes hit isolated from the rumen.
4 Best Greengenes hit isolated from the gastro-intestinal tract of ruminants.
Statistical analysis of OTU richness and diversity of non-infected fermenters A-C with regard to sampling day.
| Sampling day | |||||||
|---|---|---|---|---|---|---|---|
| Steady-state period | Experimental period | ||||||
| 5 | 6 | 7 | 10 | 12 | 15 | ||
| observed OTUs | 1673 ± 102ac | 1690 ± 44a | 1704 ± 116ac | 1523 ± 75bc | 1486 ± 46b | 1390 ± 103b | < 0.001 |
| Chao 1 | 2652 ± 61bc | 2807 ± 58a | 2735 ± 43ab | 2543 ± 110ce | 2362 ± 77de | 2241 ± 99d | < 0.001 |
| Shannon | 8.01 ± 0.27 | 8.07 ± 0.09 | 8.08 ± 0.24 | 8.03 ± 0.29 | 8.17 ± 0.14 | 7.77 ± 0.39 | NS |
*Time contrasts were tested between all groups and non-significant differences were marked with same letters.
NS = not statistically significant.
Fig 2UniFrac distances of amplicon sequencing data depicted as PCoA Plot with sampling days shown in different colors.
The percent variation explained by each principal coordinate is indicated by the axes. A: weighted and B: unweighted UniFrac with only non-infected fermenters (Fig 1B, fermenters A-C). C: weighted and D: unweighted UniFrac with fermenters used for the C. perfringens spiking experiment (Fig 1B, fermenters D-F). Only fermenters at days 10, 12, and 15 are spiked with C. perfringens. Native rumen fluid samples of donor animals are included in each panel (Native rumen fluid).
Fig 3LEfSe analysis.
Phylotypes which were statistically significantly enriched at a certain time point were highlighted in color in the cladogram. To investigate shifts along the time line only the non-infected fermenters A-C were used.
Metabolite concentrations, redox potential and pH of non-infected fermenters A-C with regard to sampling time points.
| Sampling day | |||||||
|---|---|---|---|---|---|---|---|
| Steady-state period | Experimental period | ||||||
| 5 | 6 | 7 | 10 | 12 | 15 | ||
| Alanine [μM] | 4.55 ± 1.94 | 7.56 ± 1.96 | 5.39 ± 0.64 | 6.13 ± 0.64 | 7.51 ± 0.88 | 3.77 ± 0.69 | NS |
| Aspartate [μM] | 12.23 ± 1.10 | 12.33 ± 1.70 | 12.73 ± 0.31 | 12.73 ± 0.65 | 15.17 ± 1.31 | 12.5 ± 0.56 | NS |
| Citrulline [μM] | 1.93 ± 0.15 | 2.14 ± 0.46 | 2.15 ± 0.40 | 2.11 ± 0.20 | 2.29 ± 0.12 | 2.20 ± 0.48 | NS |
| Glutamate [μM] | 21.4 ± 3.74 | 21.20 ± 4.23 | 20.03 ± 1.65 | 19.40 ± 1.23 | 22.10 ± 1.81 | 17.30 ± 1.41 | NS |
| Isoleucine [μM] | 0.60 ± 0.07 | 1.35 ± 0.36 | 1.34 ± 0.61 | 1.58 ± 0.02 | 1.94 ± 0.41 | 1.03 ± 0.41 | NS |
| Leucine [μM] | 1.75 ± NA | NA | NA | 3.26 ± NA | NA | NA | NA |
| Lysine [μM] | 1.93 ± 0.78 | 3.54 ± 2.42 | 4.73 ± 2.14 | 4.58 ± 1.35 | 5.08 ± 1.58 | 2.32 ± 0.92 | NS |
| Ornithine [μM] | 1.14 ± 0.40 | 0.90 ± 0.01 | NA | NA | NA | NA | NS |
| Phenylalanine [μM] | NA | 0.59 ± 0.14 | 0.49 ± 0.35 | 0.62 ± 0.27 | 0.67 ± 0.40 | 0.22 ± 0.15 | NS |
| Proline [μM] | 1.43 ± NA | 2.10 ± 0.49 | 1.88 ± 0.50 | 1.96 ± 0.22 | 2.31 ± 0.81 | 1.76 ± 0.50 | NS |
| Serine [μM] | 1.09 ± NA | 1.08 ± NA | 1.66 ± 0.74 | 2.03 ± NA | 1.81 ± 0.20 | 1.41 ± 0.55 | NS |
| Threonine [μM] | 0.78 ± 0.02 | 1.12 ± 0.42 | 0.84 ± 0.34 | 1.20 ± 0.17 | 1.31 ± 0.49 | 0.86 ± 0.12 | NS |
| Tyrosine [μM] | NA | NA | NA | 0.53 ± NA | 0.52 ± NA | NA | NA |
| Valine [μM] | NA | NA | NA | NA | 0.63 ± NA | NA | NA |
| Histamine [μM] | 0.06 ± 0.05 | 0.15 ± 0.15 | NA | 0.06 ± NA | 0.03 ± NA | NA | NS |
| Methionine sulfoxide [μM] | 0.56 ± 0.16 | 0.46 ± 0.11 | 0.54 ± 0.33 | 0.61 ± 0.26 | 0.69 ± 0.29 | 0.57 ± 0.15 | NS |
| Phenylethylamine [μM] | 3.26 ± 0.51 | 3.40 ± 0.21 | 3.25 ± 0.07 | 3.87 ± 0.34 | 3.27 ± 0.30 | 3.57 ± 0.49 | NS |
| Putrescine [μM] | 2.48 ± 0.44 | 2.72 ± 0.39 | 1.89 ± 0.12 | 2.20 ± 0.38 | 2.54 ± 0.05 | 1.86 ± 0.08 | 0.048 |
| Serotonin [μM] | 0.08 ± NA | 0.08 ± 0.01 | 0.08 ± 0.00 | 0.09 ± 0.01 | 0.08 ± 0.01 | 0.08 ± 0.01 | NS |
| Spermidine [μM] | 1.84 ± 0.23 | 1.86 ± 0.07 | 1.61 ± 0.27 | 2.06 ± 0.35 | 1.92 ± 0.24 | 1.58 ± 0.22 | NS |
| Hexose [μM] | 44.00 ± 6.11 | 48.20 ± 7.88 | 45.00 ± 7.23 | 52.00 ± 13.97 | 47.83 ± 7.64 | 39.55 ± 3.04 | NS |
| pH | 6.84 ± 0.04 | 6.82 ± 0.01 | 6.8 ± 0.05 | 6.74 ± 0.06 | 6.76 ± 0.04 | 6.83 ± 0.04 | NS |
| Redox potential [mV] | -271 ± 14 | -275 ± 8 | -264 ± 7 | -294 ± 15 | -265 ± 11 | -259 ± 6 | NS |
| Ammonia [mM] | 7.98 ± 0.45 | 7.14 ± 0.20 | 7.12 ± 0.23 | 7.74 ± 0.62 | 8.19 ± 0.14 | 7.50 ± 0.17 | NS |
| C2 [mmol/d] | 16.70 ± 1.29 | 15.66 ± 1.41 | 15.57 ± 1.06 | 18.50 ± 1.33 | 16.58 ± 2.24 | 14.51 ± 1.85 | NS |
| C3 [mmol/d] | 7.01 ± 0.80 | 6.57 ± 0.87 | 6.17 ± 0.34 | 7.76 ± 0.77 | 6.83 ± 0.96 | 5.70 ± 1.01 | NS |
| C4 [mmol/d] | 4.67 ± 0.71 | 5.29 ± 0.66 | 5.51 ± 0.92 | 6.64 ± 0.17 | 6.26 ± 0.60 | 5.51 ± 1.01 | NS |
| iC5 [mmol/d] | 0.86 ± 0.10 | 0.90 ± 0.08 | 0.90 ± 0.09 | 0.85 ± 0.09 | 0.77 ± 0.16 | 0.77 ± 0.10 | NS |
| C5 [mmol/d] | 1.39 ± 0.11 | 1.90 ± 0.19 | 1.85 ± 0.34 | 2.57 ± 0.20 | 2.43 ± 0.24 | 2.15 ± 0.44 | NS |
NA = not available, concentration was below the detection limit.
NS = not statistically significant.
Total bacteria qPCR results of the control fermenters (fermenter A-C).
| Sampling day | |||||||
|---|---|---|---|---|---|---|---|
| Steady-state period | Experimental period | ||||||
| 5 | 6 | 7 | 10 | 12 | 15 | ||
| Gene copy numbers | 5.38E+07b | 6.04E+07b | 5.15E+07b | 5.70E+07b | 8.50E+07a | 1.04E+08a | < 0.001 |
| Standard deviation | 9.99E+06 | 1.05E+07 | 9.06E+06 | 4.08E+06 | 3.90E+06 | 2.22E+07 | |
*Time contrasts were tested between all groups and non-significant differences were marked with same letters.
Fig 4LEfSe analysis.
Phylotypes which are statistically significantly enriched in the non-infected vessels or in the C. perfringens infected vessels were highlighted in color in the cladogram. A = day 10, B = day 12, and C = day 15.
Metabolite concentration between non-infected (A-C) and infected fermenters (D-F).
| Fermenters | ||||||||
|---|---|---|---|---|---|---|---|---|
| A-C | D-F | |||||||
| Leucine [μM] | Sampling day 10 | 3.26 | ± | 0.02 | 6.49 | ± | 2.04 | NS |
| Sampling day 12 | NA | ± | NA | 7.76 | ± | 0.76 | 0.037 | |
| Sampling day 15 | NA | ± | NA | 5.33 | ± | 0.88 | 0.037 | |
| Ornithine [μM] | Sampling day 10 | NA | ± | NA | 1.86 | ± | 0.98 | NS |
| Sampling day 12 | NA | ± | NA | 1.65 | ± | 0.62 | 0.037 | |
| Sampling day 15 | NA | ± | NA | 1.10 | ± | 0.55 | NS | |
| Phenylalanine [μM] | Sampling day 10 | 0.62 | ± | 0.27 | 3.44 | ± | 1.38 | 0.050 |
| Sampling day 12 | 0.67 | ± | 0.40 | 3.93 | ± | 0.45 | 0.050 | |
| Sampling day 15 | 0.22 | ± | 0.15 | 2.48 | ± | 0.77 | 0.050 | |
| Threonine [μM] | Sampling day 10 | 1.20 | ± | 0.17 | 2.42 | ± | 0.89 | 0.050 |
| Sampling day 12 | 1.31 | ± | 0.49 | 2.38 | ± | 0.50 | 0.050 | |
| Sampling day 15 | 0.86 | ± | 0.12 | 1.40 | ± | 0.34 | 0.050 | |
| Tyrosine [μM] | Sampling day 10 | 0.53 | ± | NA | 1.42 | ± | 0.94 | 0.046 |
| Sampling day 12 | 0.52 | ± | NA | 1.66 | ± | 0.45 | 0.046 | |
| Sampling day 15 | NA | ± | NA | 0.78 | ± | 0.27 | 0.037 | |
| Valine [μM] | Sampling day 10 | NA | ± | NA | 7.06 | ± | 3.45 | 0.037 |
| Sampling day 12 | NA | ± | NA | 7.67 | ± | 1.63 | 0.046 | |
| Sampling day 15 | NA | ± | NA | 4.14 | ± | 1.29 | 0.037 | |
NA = not available, concentration was below the detection limit.
NS = not statistically significant.